Analysis

Neurogene Inc. Full Year 2025 Financial Overview

Neurogene Inc. Full Year 2025 Financial Overview

Company Overview Neurogene is a clinical-stage biotechnology company focused on developing genetic medicines for individuals and families affected by rare…

Velo3D 2025 Financial Performance Review

Company Overview Velo3D, Inc. is an additive manufacturing technology company that transforms aerospace and defense supply chains with metal 3D…

Fennec Pharmaceuticals 2025 Financial Update

 Company Overview Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer patients. The…

NVIDIA (NVDA) Re-Entry Into China’s AI Chip Market: Products, Policy, Competition, and Investor Impact

NVIDIA (NVDA) is positioning for a potential re-acceleration of data center growth by adapting its AI accelerator lineup for China…

Avalo Therapeutics 2025 Financial Review

Company Overview Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases. The company's…

WeRide Inc. 2025 Financial Performance Review

Company Overview WeRide Inc. is a global leader in autonomous driving technology and the first publicly traded robotaxi company. Key…

Surrozen 2025 Financial Results Review

Company Overview Surrozen is a biotechnology company developing targeted therapeutics that harness Wnt signaling to address sight-threatening ophthalmic conditions. Key…

PPHC Q4 and FY 2025 Financial Review

Company Overview Public Policy Holding Company, Inc. (PPHC) is a global strategic communications provider offering advisory services across Government Relations,…

Cabaletta Bio Q4 and FY 2025 Financial Review

Company Overview Cabaletta Bio is a late-stage clinical biotechnology company focused on developing targeted cell therapies specifically for patients with…

Arbutus Biopharma 2025 Financial Review

 Company Overview Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company focused on infectious diseases.  Key Financial Figures For the year…